Healthy volunteers help uncover drug combo safety
NCT ID NCT06717100
First seen Jan 11, 2026 · Last updated May 15, 2026 · Updated 15 times
Summary
This completed Phase 1 trial enrolled 24 healthy adults to see if taking deupirfenidone and nintedanib together causes any drug interactions. Participants received the drugs alone and in combination over up to 60 days. Researchers measured drug levels in the blood and tracked any side effects. The goal was to gather safety and dosing information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG INTERACTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nucleus Network Pty Ltd (Commercial Rd and St Kilda Rd) - VIC
Melbourne, Victoria, 3004, Australia
Conditions
Explore the condition pages connected to this study.